The determined T/PSA cutoff of 0.8 (OR: 0.10, 95% CI: 1.83–63.39, p = 0.008) yielded a sensitivity of 82.4% and a specificity of 72.7%, indicating that it may help avoid unnecessary invasive procedures without compromising cancer detection. The gene discussed is KLK3; the disease is cancer.